Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O43660 | Pleiotropic regulator 1 | ||
O43674 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial | ||
O43760 | Synaptogyrin-2 | ||
O43768 | Alpha-endosulfine | ||
O43852 | Calumenin | ||
O43854 | EGF-like repeat and discoidin I-like domain-containing protein 3 | ||
O43909 | Exostosin-like 3 | ||
O60279 | Sushi domain-containing protein 5 | ||
O60309 | Leucine-rich repeat-containing protein 37A3 | ||
O60353 | Frizzled-6 |
Pathway Name | Organism |
---|---|
Ficolins bind to repetitive carbohydrate structures on the target cell surface | Sus scrofa |
Initial triggering of complement | Mus musculus |
Initial triggering of complement | Gallus gallus |
Initial triggering of complement | Xenopus tropicalis |
Initial triggering of complement | Sus scrofa |
Initial triggering of complement | Bos taurus |
Initial triggering of complement | Canis familiaris |
Initial triggering of complement | Rattus norvegicus |
Initial triggering of complement | Homo sapiens |
Lectin pathway of complement activation | Bos taurus |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
28546425 | The first crystal structure of a family 129 glycoside hydrolase from a probiotic bacterium reveals critical residues and metal cofactors | Sato M | 2017 Jul 21 |
|
28724971 | Computational design of a symmetrical β-trefoil lectin with cancer cell binding activity | Terada D | 2017 Jul 19 |
|
28644609 | GalNAc-Tyrosine Is a Ligand of Plant Lectins, Antibodies, and Human and Murine Macrophage Galactose-Type Lectins | Gibadullin R | 2017 Jul 14 |
|
28671633 | L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins | Pavlikova L | 2017 Jul 03 |
|
28096352 | Recognition of protein-linked glycans as a determinant of peptidase activity | Noach I | 2017 Jan 17 |
|
28085993 | N‐Acetylgalactosamine‐Targeted Delivery of Dendrimer‐Doxorubicin Conjugates Influences Doxorubicin Cytotoxicity and Metabolic Profile in Hepatic Cancer Cells | Kuruvilla SP | 2017 Jan 13 |
|
27959715 | A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 | Fitzgerald K | 2017 Jan 05 |
|
28052224 | Oligonucleotide Therapeutics — A New Class of Cholesterol-Lowering Drugs | Khvorova A | 2017 Jan 05 |
|
28129130 | Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate | Zimmermann TS | 2017 Jan 04 |
|
28035807 | Proteomics Analysis of O-GalNAc Glycosylation in Human Serum by an Integrated Strategy | Qin H | 2017 Feb 7 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025